National Hospital Organisation Kyushu Cancer Centre Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2009
NCT00937664
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

National Hospital Organization Kyushu Cancer Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 1)

Lung Neoplasms (Phase 1)

Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 6